TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
KMDA

Kamada

Healthcare · Drug Manufacturers - Specialty & Generic

8.70$ +0.0% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Balance Sheet

Kamada (KMDA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 379 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet KMDA
Line item 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– 42 63 92 85 89 139 120 102 100 122 138 174 211 319 322 355 372 379
– 26 44 71 67 70 118 98 81 77 97 111 144 178 130 139 170 184 193
– 13 30 26 24 17 59 15 5.0 10.0 13 18 43 70 19 34 56 78 75
– 13 31 46 41 34 74 52 28 29 43 51 74 109 19 34 56 78 75
– 4.1 5.4 14 8.2 14 20 19 25 22 32 29 25 23 36 28 21 23 29
– 8.1 8.1 11 15 21 22 25 26 26 21 29 43 43 72 73 88 79 85
– – – – 17 19 21 22 21 23 25 25 29 29 29 29 – – –
– – – – – – – – – – – – – – 30 30 30 30 30
– 4.1 5.4 0.0 0.0 0.2 0.1 0.1 0.1 22 – 0.1 0.3 1.5 123 117 110 102 96
– 29 33 65 63 61 49 39 29 33 33 26 38 32 142 146 111 113 110
– 9.1 9.0 20 23 29 33 31 23 27 29 24 33 25 54 76 50 49 47
– 1.5 0.1 0.0 0.1 5.4 8.7 7.5 0.0 0.4 0.6 0.6 1.5 1.3 3.8 5.5 1.4 1.6 2.1
– 4.9 5.9 12 13 12 14 17 17 16 18 17 25 16 25 33 25 28 23
– – – – 22 19 7.5 1.0 0.2 1.4 1.4 0.7 0.3 0.0 17 13 – – –
– 13 30 26 23 28 90 81 73 67 89 112 135 179 177 176 244 259 269
– -50 -72 -92 -89 -81 -80 -93 -105 -111 -105 -83 -61 -44 -46 -48 -40 -26 -17
11 13 25 25 28 29 33 36 36 36 38 41 41 45 45 45 54 58 58

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?